Insulin aspart, recombinant Subcutaneous and Ipratropium inhalation
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ipratropium inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ipratropium Inhalation Aerosol
- Insulin aspart, recombinant Subcutaneous-Ipratropium Inhalation Solution
- Insulin aspart, recombinant Subcutaneous-Ipratropium Inhalation, oral/nebulization
- Insulin aspart, recombinant Subcutaneous-Ipratropium nasal
- Insulin aspart, recombinant Subcutaneous-Ipratropium Nasal 0.03
- Insulin aspart, recombinant Subcutaneous-Ipratropium Nasal 0.06
- Ipratropium inhalation-Insulin degludec
- Ipratropium inhalation-Insulin Degludec (U-100) Prefilled Pens
- Ipratropium inhalation-Insulin Degludec (U-100) Vials
- Ipratropium inhalation-Insulin Degludec (U-200) Prefilled Pens
- Ipratropium inhalation-Insulin degludec and liraglutide
- Ipratropium inhalation-Insulin degludec and liraglutide Subcutaneous